Latest results FY2025 · Prices updated Oct 30, 2026
HQ: Kobe, HyogoFounded 201149 employeesWebsite
A holding company with businesses centered on cosmetics, as well as pharmaceuticals and foods. It offers products backed by proprietary research and development through direct and online sales.
Business segments (share of revenue)
Latest results
FY2025
vs. same period a year earlier
Company forecastFY2026
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Cosmetics Products Business | 78% | ¥50.5B | ¥12.3B | 24.3% |
| Pharmaceuticals and Food | 18% | ¥11.5B | ¥980M | 8.5% |
| Other Business Operations | 4% | ¥2.7B | ¥301M | 11.3% |
Close (Oct 30, 2026)
¥4,565+5.3% (1Y)
Noevir +5.3% over 1Y, 19.5pt below the industry average (4 companies, +24.8%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2025FY | ¥64.7B | ¥11.1B | ¥8.0B | ¥76.5B | — |
Sources: annual securities reports, earnings releases and other public disclosures (Mar 2026)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
